AmniSure® solves a long-standing problem in obstetric practice – diagnosis of ruptured fetal membranes (ROM). Premature ROM (PROM) occurs in about one out of ten pregnant women, and constitutes the major factor of pre-and post-natal complications. PROM occurs when a woman’s amniotic fluid breaks prematurely (not followed by labor in 24-48 hours). If the rupture of the amniotic sac that results in the leakage of the fluid is not detected and treated in a timely and accurate manner (during 24 hours since the rupture’s occurrence), infection and other serious complications for the neonate and the mother may occur.
AmniSure® detects the PAMG-1 protein in the amniotic fluid, and allows accurate diagnosis so early intevention can occur.
AmniSure® is recommended by the RANZCOG guidelines.